BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36980737)

  • 1. Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System.
    Barbieri MA; Sorbara EE; Russo G; Cicala G; Franchina T; Santarpia M; Silvestris N; Spina E
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
    di Mauro G; Zinzi A; Scavone C; Mascolo A; Gaio M; Sportiello L; Ferrajolo C; Rafaniello C; Rossi F; Capuano A
    Drug Saf; 2021 Mar; 44(3):337-349. PubMed ID: 33351170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System.
    Sorbara EE; Barbieri MA; Russo G; Cicala G; Spina E
    BioDrugs; 2024 Mar; 38(2):275-285. PubMed ID: 38402495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
    Zalcberg JR
    Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System.
    Barbieri MA; Russo G; Sorbara EE; Cicala G; Franchina T; Santarpia M; Speranza D; Spina E; Silvestris N
    Front Oncol; 2023; 13():1268672. PubMed ID: 38023143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization.
    Khurana A; Arora MK; Dubey H
    Daru; 2023 Dec; 31(2):107-118. PubMed ID: 37221442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Type I and II tyrosine kinase inhibitors-avapritinib and sunitinib-in refractory gastrointestinal stromal tumor after failure to multi-line therapy: a case report.
    Guo X; Huang S; Shi Y; Guan Z; Chen S; Feng Y; Xia Y; Zhang X
    Ann Transl Med; 2022 Sep; 10(18):1026. PubMed ID: 36267752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database.
    Rastogi S; Kalaiselvan V; Bin Jardan YA; Zameer S; Sarwat M
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
    Wallerstedt SM; Brunlöf G; Sundström A
    Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric adverse reactions to non-selective RET multi-kinase inhibitors: a large-scale pharmacovigilance analysis.
    Wang X; Yin D; Tang Y; Xiao F; Wang S
    Front Pharmacol; 2023; 14():1209933. PubMed ID: 37465525
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System.
    Velișcu EM; Liguori V; Anatriello A; Maniscalco GT; Cantone A; Di Costanzo L; Stefanelli P; Scavone C; Capuano A
    Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
    Yonkus JA; Alva-Ruiz R; Grotz TE
    Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
    Mohammadi M; Gelderblom H
    Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance.
    Pop G; Farcaș A; Butucă A; Morgovan C; Arseniu AM; Pumnea M; Teodoru M; Gligor FG
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database.
    Sportiello L; Di Napoli R; Balzano N; Mascolo A; Ruggiero R; Di Costanzo L; Monaco D; Maniscalco GT; Capuano A
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
    Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
    Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System.
    Scavone C; Mascolo A; Ruggiero R; Sportiello L; Rafaniello C; Berrino L; Capuano A
    Front Pharmacol; 2020; 11():428. PubMed ID: 32351386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials.
    Wu L; Zhang Z; Yao H; Liu K; Wen Y; Xiong L
    Drug Des Devel Ther; 2014; 8():2061-7. PubMed ID: 25378911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?
    Senchak J; Ahr K; von Mehren M
    Curr Treat Options Oncol; 2022 May; 23(5):749-761. PubMed ID: 35349049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.